PRSS16 expression based on | ||||||||||||||||||||||||||||||||||||||||||||||||||
CESC : Cervical squamous cell carcinoma*
Please note that low number(<10) of normal samples considered.
| ||||||||||||||||||||||||||||||||||||||||||||||||||
CESC : Cervical squamous cell carcinoma*
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 8 samples.
| ||||||||||||||||||||||||||||||||||||||||||||||||||
CESC : Cervical squamous cell carcinoma*
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 37 samples. Two samples from Native Hawaiian and seven samples from American Indians are not considered in the above plot.
| ||||||||||||||||||||||||||||||||||||||||||||||||||
CESC : Cervical squamous cell carcinoma*
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 46 samples.
| ||||||||||||||||||||||||||||||||||||||||||||||||||
CESC : Cervical squamous cell carcinoma*
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample. One sample from patients below 21 years are not considered in above plot.
| ||||||||||||||||||||||||||||||||||||||||||||||||||
CESC : Cervical squamous cell carcinoma*
Please note that low number(<10) of normal samples considered.
Note
Histological subtype information is not available for 1 sample.
| ||||||||||||||||||||||||||||||||||||||||||||||||||
CESC : Cervical squamous cell carcinoma
| ||||||||||||||||||||||||||||||||||||||||||||||||||
CESC : Cervical squamous cell carcinoma*
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 46 samples and cancer in nearby lymph nodes cannot be measured (NX) in 66 samples.
|